Taiwan’s neuroendoscopes market is expected to grow steadily, driven by rising neurological disorders, an aging population, and increased adoption of minimally invasive neurosurgical technologies, according to the report.
The firm noted that demand in Asia-Pacific is led by Japan and China, whilst Taiwan remains a smaller, highly specialised market centered in tertiary hospitals.
Growth is expected to come mainly from upgrades to high-definition imaging systems and minimally invasive surgical workflows, rather than broad-based adoption.
Taiwan accounted for nearly 3{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481} of the Asia-Pacific neuroendoscopes market in 2025.
Adoption is expected to remain specialised and procurement-led, with growth tied to gradual upgrades to high-definition endoscopic visualisation and minimally invasive neurosurgical workflows.
Related: One in Five APAC Doctors Leaving Over Strain
Aakansha Pankaj, medical devices analyst, said: “However, the high capital and servicing costs of imported reusable systems can constrain wider penetration beyond leading institutions, potentially sustaining a center-of-excellence–driven adoption pattern.”
Brain Navi Biotechnology received approval from the Taiwan Food and Drug Administration for its single-use 3D neuroendoscope, “KrystoLens.”
The disposable system is designed to remove sterilisation and reprocessing steps, improving operating room efficiency and enabling a shift toward more predictable per-procedure costs.
High-definition imaging upgrades and minimally invasive surgery are driving the adoption of neuroendoscopy in Taiwan, with minimally invasive neurosurgical technologies playing a key role in this trend.
Neuroendoscopy Market Trends
The Asia-Pacific neuroendoscopes market is led by Japan and China, with Taiwan being a smaller but highly specialised market.
Related: 17 Professional Tips to Improve Your Healthy News
The market is expected to grow at a compound annual growth rate of around 4{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481} through 2036, driven by rising neurological disorders and an aging population.
Key Drivers of Growth
The key drivers of growth in the neuroendoscopy market are high-definition imaging upgrades and minimally invasive surgical workflows.
These advancements are expected to improve patient outcomes and reduce recovery times, making them attractive to hospitals and medical institutions, such as those using health care systems.
In Taiwan, the adoption of neuroendoscopy is expected to remain specialised and procurement-led, with growth tied to gradual upgrades to high-definition endoscopic visualisation and minimally invasive neurosurgical workflows.
The market for neuroendoscopes in Taiwan is small but highly specialised, with a focus on tertiary hospitals and leading medical institutions.